BRAFTOVI(Encorafenib) Side Effects

Common side effects of TEMBEXA® include gastrointestinal issues, such as diarrhea, nausea, vomiting, and abdominal pain, affecting at least 2% of treated patients.

Adverse Reactions to TEMBEXA®

Hepatic side effects such as increased liver enzymes (ALT, AST) and elevated bilirubin levels have also been observed, necessitating ongoing liver monitoring during treatment. There is also a risk of carcinogenicity, as TEMBEXA® is considered a potential human carcinogen based on animal studies.

If gastrointestinal adverse events are severe, the second dose may be withheld. Additionally, patients should avoid concomitant use with intravenous cidofovir due to potential interactions.

Related Columns

Encorafenib(BRAFTOVI)

For the treatment of melanoma, colorectal cancer (CRC), and non-small cell lung...

WeChat Scan
Free Inquiry

What are the side effects of Encorafenib?

Encorafenib IS AN ORAL SMALL MOLECULE BRAF INHIBITOR DEVELOPED BY ARRAY BIOPHARMA IN THE UNITED STATES. In the Chinese market, the French company Pierre Fabre has obtained an exclusive commercializati...

Adverse effects of Encorafenib(BRAFTOVI)

Encorafenib (BRAFTOVI) is a therapeutic drug that targets BRAF gene mutations, which may cause a series of adverse reactions while bringing significant efficacy. Adverse effects of Encorafenib (BRAFTO...

What are the side effects of Encorafenib?

Encorafenib in combination with bimetinib is indicated for the treatment of adult patients with metastatic NSCLC detected by an FDA-approved test with a BRAF V600E mutation. The approval builds on pos...